Ordenar

Buscar

01/01/2026 Incretin-based Agents and Metabolic Dysfunction-associated Steatotic Liver Disease
Muzurovic, E, Haluzik, M, Horváth, L, Vlacho, B, Mauricio, D. Incretin-based Agents and Metabolic Dysfunction-associated Steatotic Liver Disease. CURRENT PHARMACEUTICAL DESIGN. 2026; 32(20)DOI:10.2174/0113816128378484250619080753. PMID:40641020. IF:2.800(Q2/5D).
01/01/2026 E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 3rd eNMD Congress: Pisa, Italy, 29-30 October 2021: Remote Monitoring: New Solutions for New Avenues in Neuromuscular Disorders
Schirinzi, E, Bochicchio, MA, Lochmüller, H, Vissing, J, Jordie-Diaz-Manerae, Evangelista, T, Plançon, JP, Fanucci, L, Marini, M, Tonacci, A, Mancuso, M, Segovia-Kueny, S, Toscano, A, Angelini, C, Schoser, B, Sacconi, S, Siciliano, G. E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 3rd eNMD Congress: Pisa, Italy, 29-30 October 2021: Remote Monitoring: New Solutions for New Avenues in Neuromuscular Disorders. Journal Of Neuromuscular Diseases. 2026; 13(1)DOI:10.3233/JND-230091. PMID:38728200. IF:3.400(Q2/3D).
01/01/2026 Practice effects as a dynamic biomarker of early cognitive change in far-from-onset Huntington's disease
Franch-Marti, C, Puig-Davi, A, Rodriguez-Antiguedad, J, Perez-Perez, J, Olmedo-Saura, G, Ruiz-Barrio, I, Bojtos, L, Perez-Carasol, L, Tort-Merino, A, Pagonabarraga, J, Kulisevsky, J, Martinez-Horta, S. Practice effects as a dynamic biomarker of early cognitive change in far-from-onset Huntington's disease. Brain Communications. 2026; 8(3)DOI:10.1093/braincomms/fcag210. PMID:42339152. IF:(Q/D).
01/01/2026 Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter study
Ellebaek, E, Weichenthal, M, Gavrilova, I, Asher, N, Terheyden, P, Utikal, J, Suljeviic, AJ, Pföhler, C, Stojkovski, I, Herbst, RA, Ugurel, S, Ruhlmann, C, Berrocal, A, Majem, M, Dujovic, B, Sabaric, V, Duvancic, T, Soria, A, Donia, M, Schmidt, H, Friis, RB, Gerasimov, A, Shalamanova-Deleva, G, Kontilev, A, Lev-Ari, S, Shapira, R, Piccin, L, Minisini, A, Özdemir, BC, Teterycz, P, Mariuk-Jarema, A, Ziogas, D, Anastasopoulou, A, Stefanou, D, Gutiérrez, L, Gebhardt, C, Dummer, R, Hauschild, A, Mohr, P, von Wasielewski, I, Meier, F, Haanen, J, Svane, IM, Ascierto, PA, Mangana, J, Rutkowski, P, Gogas, H, Bastholt, L, Schadendorf, D. Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter study. Ejc Skin Cancer. 2026; 4DOI:10.1016/j.ejcskn.2025.100773. PMID:. IF:(Q/D).
01/01/2026 Dynamic Hyperinflation in Patients With Moderate-Severe Asthma: Relationship With Clinical Control and Small Airway Dysfunction
Saldaña-Pérez, LE, Pariente, JS, Serrano, CC, Plaza, V, Ali-García, I, Lancharro, FJC, Cuellar, SS, Onieva, AIG, Mardones, A, Sánchez, EC, Esquerre, MM, Galera-Martínez, R, Reyes, PV, Arranz, IO, Marcos, MC, Bernáldez, CB, Astiárraga, IL, Díaz-Campos, RM, García-Río, F. Dynamic Hyperinflation in Patients With Moderate-Severe Asthma: Relationship With Clinical Control and Small Airway Dysfunction. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2026; 36(3)DOI:10.18176/jiaci.1088. PMID:40737072. IF:4.800(Q1/1D).
01/01/2026 Can NT-proBNP Enhance the Accuracy of Angiogenic Factors in the Short-Term Prediction of Preeclampsia?
Garrido-Giménez, C, Nan, MN, Cruz-Lemini, M, García-Manau, P, Garcia-Osuna, A, Ullmo, J, Mora, J, Sánchez-García, O, Medina-Mallén, MD, Choliz, M, Platero, J, Llurba, E. Can NT-proBNP Enhance the Accuracy of Angiogenic Factors in the Short-Term Prediction of Preeclampsia?. CLINICAL CHEMISTRY. 2026; 72(1)DOI:10.1093/clinchem/hvaf135. PMID:41468134. IF:6.300(Q1/1D).
01/01/2026 Association Between Complications and Death Within 30 Days After Orthopedic Surgery: Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION) Substudy
Park, LJ, Devereaux, PJ, Patel, A, Tandon, V, Heels-Ansdell, D, Thabane, L, Serrano, PE, Chan, MTV, Szczeklik, W, Srinathan, S, Garutti, I, Urrutia, G, Guerra-Farfan, E, Khalik, HA, Duceppe, E, Ofori, S, Marcucci, M, Conen, D, Wang, MK, Spence, J, Tushinski, D, Bali, K, Adili, A, Khanna, V, Tonelli, AC, Mulazzani, F, Jiang, WJ, Ayeni, OR, Slobegean, G, Miclau, T, Bhandari, M, Borges, FK. Association Between Complications and Death Within 30 Days After Orthopedic Surgery: Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION) Substudy. Jmir Perioperative Medicine. 2026; 9DOI:10.2196/90823. PMID:42263161. IF:(Q/D).
01/01/2026 European Code Against Cancer, 5th edition - diet, excess body weight, physical activity, sedentary behavior, breastfeeding, and cancer
Leitzmann, MF, Bakogianni, I, Anderson, AS, Bauld, L, Fernandez, E, Morris, S, Srour, B, Vardavas, C, Vlad, I, Vuik, S, Weijenberg, M, Figuls, MRI, Rigau, D, Feliu, A, Zeeb, H, Schüz, J, D'Souza, E, Ritchie, D, Espina, C, Riboli, E. European Code Against Cancer, 5th edition - diet, excess body weight, physical activity, sedentary behavior, breastfeeding, and cancer. Molecular Oncology. 2026; 20(1)DOI:10.1002/1878-0261.70201. PMID:41542809. IF:4.500(Q2/3D).